Analgesics in Asia Pacific
Asia Pacific is the second largest region in the world for analgesics sales behind North America and is also the fastest growing region, driven by an ageing population and an increasing preference for topical analgesics over systemics. Looking forward to 2022, Asia Pacific is expected to continue growing at a rapid pace and to overtake North America as the largest global market by 2019 with USD6.0 billion in sales to North America’s USD5.6 billion.
Euromonitor International’s Analgesics in Asia Pacific global briefing examines the size, growth trends and potential opportunities in the Consumer Health market. The strategic analyses include assessing the impacts of changing regulations, research breakthroughs and public health concerns on both the market and leading companies. Consumer attitudes towards the products and their personal healthcare needs are also explored.
Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook